AMRI in Parenteral Drug Product Pact
By

Part of the special news roundup of DCAT member companies for the DCAT Week ’17 Special Edition of DCAT Value Chain Insights (April 5, 2017)

AMRI, a contract research and manufacturing organization, partnered with Ferrer, a privately held Barcelona, Spain-headquartered pharmaceutical company, and Accord Healthcare, the marketing arm of Intas Pharmaceuticals, an Ahmedabad, India-headquartered pharmaceutical formulation development, manufacturing, and marketing company, to jointly develop and manufacture an undisclosed parenteral drug product.

The companies will jointly develop and manufacture the parenteral drug product for registration and subsequent commercialization in the US with the option to partner on additional drug products.

Under the agreement, AMRI will work with Ferrer to develop and initially provide cGMP manufacturing and analytical support for the registration of the new product. Accord Healthcare will be responsible for advancing the product candidate through regulatory submission and commercialization.

Source: AMRI

Leave a Reply

Your email address will not be published. Required fields are marked *